Ambu's growth continues, and in the first half of 2008/09, revenue was up 10%
measured in local currencies, which is considerably more than the estimated
market growth of 3-5%. The operating profit for Q2 was DKK 25.0m against DKK
24.5m in the same period last year after non-recurring and special items.
Since autumn 2008, Ambu has been focusing on launching more new products,
intensifying sales efforts and streamlining operations. These priorities
impacted the half year positively.
The health sector is affected by the global crisis, but Ambu is currently only
sensing the economic downturn to a very limited extent. The outlook for revenue
and profit for 2008/09 is unchanged relatively to earlier announcements before
special items in the form of the costs of conducting the pending patent cases.
